Cure research at CROI 2018: defining and reducing the reservoir and the risks from interrupting treatment
30 March 2018. Related: Conference reports, Cure-related research.
CROI 18 (Retrovirus) 2011
18th Conference on Retroviruses and Opportunistic Infections (CROI) 27 February-3 March 2011, Boston
1 August 2011. Related: Conference reports.
Monitoring treatment in resource limited settings: results from PHPT-3 and Stratall ANRS12110/ESTER trials
1 August 2011. Related: Conference reports, Treatment strategies, Treatment access.
DART: high rates of viral suppression after five years and a single CD4 test with a threshold of 250 cells/mm3 could reduce unnecessary switching
1 August 2011. Related: Conference reports, Treatment strategies, Treatment access.
Lopinavir/r monotherapy used as second-line therapy in resource-limited settings
1 August 2011. Related: Conference reports, Treatment strategies, Treatment access.
Treating children previously exposed to single dose nevirapine: update on IMPAACT P1060 and NEVEREST
1 August 2011. Related: Conference reports, Pregnancy, Paediatric care.
Lopinavir/ritonavir oral solution toxicity in neonates
1 August 2011. Related: Conference reports, Paediatric care, Side effects.
Paediatric antiretroviral pipeline: darunavir and raltegravir
1 August 2011. Related: Conference reports, Antiretrovirals, Paediatric care.
Pharmacokinetics of different rifabutin dosing strategies with lopinavir/ritonavir-based ART
1 August 2011. Related: Conference reports, PK and drug interactions, TB coinfection.
Initiation of ART during breastfeeding can induce multidrug resistance in infants
1 August 2011. Related: Conference reports, Pregnancy.
18th Conference on Retroviruses and Opportunistic Infections (CROI), 27 February-3 March 2011, Boston
1 May 2011. Related: Conference reports.
When to start ART in patients co-infected with TB: results from two trials presented at CROI
1 May 2011. Related: Conference reports, Antiretrovirals, TB coinfection.
Inflammation and intervention: how does HIV cause AIDS and how does it cause disease despite ART
1 May 2011. Related: Conference reports, Antiretrovirals.
18th Conference on Retroviruses and Opportunistic Infections (CROI), 27 February-3 March 2011, Boston
1 April 2011. Related: Conference reports.
New antiretrovirals: dolutegravir, entry inhibitor (BMS-663068) and tenofovir pro-drug (GS-7340)
1 April 2011. Related: Conference reports, Antiretrovirals.
Immune-based treatment increases HIV-resistant CD4 cells in phase 1 study
1 April 2011. Related: Conference reports, Antiretrovirals.
Antiretroviral prevention: oral PrEP, gels and treatment studies
1 April 2011. Related: Conference reports, Antiretrovirals.
Further efficacy analyses from the iPrEx study
1 April 2011. Related: Conference reports, Antiretrovirals.
Topical gels as PEP and PrEP: animal and human studies
1 April 2011. Related: Conference reports, Antiretrovirals.
Maternal risk following short course HAART
1 April 2011. Related: Conference reports, Antiretrovirals, Pregnancy.
Pre-term delivery and HAART
1 April 2011. Related: Conference reports, Antiretrovirals, Pregnancy.
HAART more effective than AZT monotherapy in the Botswana PMTCT programme
1 April 2011. Related: Conference reports, Antiretrovirals, Pregnancy.
Lopinavir/r monotherapy for PMTCT
1 April 2011. Related: Conference reports, Antiretrovirals, Pregnancy.
No evidence of increased risk of MTCT with sequential pregnancies in UK and Ireland
1 April 2011. Related: Conference reports, Pregnancy.
Recently infected women at the time of delivery have a higher rate of in-utero transmission in PEPI-Malawi
1 April 2011. Related: Conference reports, Pregnancy.
Reduced CCL22 concentrations in cervicovaginal secretions from pregnant women
1 April 2011. Related: Conference reports, Pregnancy.
First results from telaprevir in HIV/HCV coinfection
1 April 2011. Related: Conference reports, Antiretrovirals, Hepatitis coinfection.
HCV reinfection rates in HIV-positive gay men
1 April 2011. Related: Conference reports.